Showing 11-20 of 23 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression | University of Florida | Sarah Kim | Cures | 01-June-2022 to 31-May-2026 | $750,000.00 |
| Network for Pancreatic Organ Donors – nPOD | University of Florida | Mark Atkinson | Cures | 01-October-2023 to 30-September-2026 | $8,100,000.00 |
| Orthogonal engineering to suppress autoreactive T cell activation in T1D cell therapy | University of Florida | Jessie Barra | Cures | 01-March-2024 to 28-February-2027 | $190,000.00 |
| Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D | University of Florida | Graciela Lorca | Cures | 01-September-2019 to 31-August-2026 | $355,941.78 |
| Tolerance signals from human pregnancy for beta cell replacement therapy | University of Florida | Edward Phelps | Cures | 01-December-2023 to 30-November-2025 | $600,000.00 |
| Prohormone convertase activity in human T1D pancreas tissue slices | University of Florida | Denise Drotar | Cures | 01-March-2025 to 29-February-2028 | $264,895.00 |
| Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation | University of Florida | Allison Bayer | Cures | 01-September-2023 to 31-March-2026 | $510,297.39 |
| Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare | Nemours Children's Clinic | Jessica Pierce | Improving Lives | 01-May-2023 to 30-April-2026 | $628,819.87 |
| JDRF T1D Coordinating Center | Jaeb Center for Health Research | Judy Sibayan | Transportfolio | 01-August-2019 to 31-August-2027 | $2,914,531.01 |
| A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema | Jaeb Center for Health Research | Adam Glassman | Improving Lives | 01-September-2022 to 01-January-2026 | $273,424.00 |